Hunter-killer peptide (HKP) for targeted therapy

被引:32
作者
Ellerby, H. Michael [2 ]
Bredesen, Dale E. [1 ]
Fujimura, Satoshi [1 ]
John, Varghese [1 ]
机构
[1] Buck Inst Age Res, Novato, CA 94945 USA
[2] Touro Univ, Coll Pharm, Vallejo, CA 94592 USA
关键词
D O I
10.1021/jm800495u
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:5887 / 5892
页数:6
相关论文
共 56 条
[1]   Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model [J].
Arap, W ;
Pasqualini, R ;
Ruoslahti, E .
SCIENCE, 1998, 279 (5349) :377-380
[2]  
Arap W, 2001, HAEMOSTASIS, V31, P30
[3]   Targeting the prostate for destruction through a vascular address [J].
Arap, W ;
Haedicke, W ;
Bernasconi, M ;
Kain, R ;
Rajotte, D ;
Krajewski, S ;
Ellerby, HM ;
Bredesen, DE ;
Pasqualini, R ;
Ruoslahti, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (03) :1527-1531
[4]  
BALTSCHEFFSKY H, 1981, MITOCHONDRIA MICROSO, P519
[5]   Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: Chemistry, biological evaluations, and therapeutic prospects [J].
Bauvois, B ;
Dauzonne, D .
MEDICINAL RESEARCH REVIEWS, 2006, 26 (01) :88-130
[6]   DESIGN OF MODEL AMPHIPATHIC PEPTIDES HAVING POTENT ANTIMICROBIAL ACTIVITIES [J].
BLONDELLE, SE ;
HOUGHTEN, RA .
BIOCHEMISTRY, 1992, 31 (50) :12688-12694
[7]   ENDOCYTOSIS AND RECYCLING OF THE FIBRONECTIN RECEPTOR IN CHO CELLS [J].
BRETSCHER, MS .
EMBO JOURNAL, 1989, 8 (05) :1341-1348
[8]   REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J].
BROOKS, PC ;
CLARK, RAF ;
CHERESH, DA .
SCIENCE, 1994, 264 (5158) :569-571
[9]   INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS [J].
BROOKS, PC ;
MONTGOMERY, AMP ;
ROSENFELD, M ;
REISFELD, RA ;
HU, TH ;
KLIER, G ;
CHERESH, DA .
CELL, 1994, 79 (07) :1157-1164
[10]   Anti-obesity drugs: a critical review of current therapies and future opportunities [J].
Clapham, JC ;
Arch, JRS ;
Tadayyon, M .
PHARMACOLOGY & THERAPEUTICS, 2001, 89 (01) :81-121